Pharmacokinetics of standard versus high-dose rifampin for tuberculosis preventive treatment: A sub-study of the 2R2 randomized controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics of standard versus high-dose rifampin for tuberculosis preventive treatment: A sub-study of the 2R2 randomized controlled trial

Published:2024-07 Issue:1 Volume:64 Page:107197
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Gafar Fajri^ORCID,Yunivita Vycke^ORCID,Fregonese Federica,Apriani Lika^ORCID,Aarnoutse Rob E.,Ruslami Rovina^ORCID,Menzies Dick

Funder

Canadian Institutes of Health Research

Publisher

Elsevier BV

Reference26 articles.

1. World Health Organization. Global Tuberculosis Report 2023. 2023. Available at: https://www.who.int/publications/i/item/9789240083851. Accessed 13 March 2024.

2. The global prevalence of latent tuberculosis: a systematic review and meta-analysis;Cohen;Eur Respir J,2019

3. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: prevention – tuberculosis preventive treatment. Geneva: 2020. Available at: https://www.who.int/publications/i/item/9789240001503.

4. World Health Organization. WHO consolidated guidelines on tuberculosis Module 4: treatment drug-susceptible tuberculosis treatment. 2022. Available at: https://www.who.int/publications/i/item/9789240048126.

5. Why do we use 600 mg of rifampicin in tuberculosis treatment?;Van Ingen;Clin Infect Dis,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP